Cryo-Cell International, Inc. announced the launch of Cryology RTS, a new reproductive tissue storage service for cryopreserved embryos, oocyctes and sperm. The service includes short and longer-term cryogenics storage, inter-facility transportation coordination, and special quarantined cryogenic storage for infectious disease positive specimens. The announcement was made at the annual meeting of the American Society of Reproductive Medicine (ASRM) on October 25.
Mercedes A. Walton, Cryo-Cell’s Chairman and Chief Executive Officer, said that the new service is “exceptionally synergistic” with the company’s core business and could be a significant source of future revenue for Cryo-Cell. The assisted reproductive technologies (ART) industry in the US alone accounts for more than $4 billion in annual revenue, and an estimated 500,000 frozen embryos are maintained in cryogenic storage.
The company expects to embark on a worldwide launch of the Cryo-Cell service following a successful launch in the United States. Cryo-Cell is based in Oldsmar FL and has nearly 215,000 clients worldwide.
